Title : Necitumumab: a new option for first-line treatment of squamous cell lung cancer.

Pub. Date : 2018 Aug

PMID : 30025476






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Expert opinion: Necitumumab plus cisplatin-gemcitabine is a first-line treatment option in SCC that improves overall survival and preserves the patient"s quality of life with a manageable toxicity profile. gemcitabine serpin family B member 3 Homo sapiens